CNDP2:一种能将新陈代谢与心血管疾病联系起来的酶?
Moizle Grace Castro Ocariza1, Louise Nancy Paton2, Evelyn Mary Templeton2
1Department of Medicine, Christchurch Heart Institute, University of Otago (Christchurch), Christchurch, New Zealand. ocamo703@student.otago.ac.nz.
Journal of cardiovascular translational research
|September 30, 2024
概括
卡诺二酶II (CNDP2) 有助于乳酸清除和代谢物调节. 这种酶是这种酶.
科学领域:
- 生物化学 生物化学
- 代谢过程中的代谢.
- 生理学 生理学 生理学
背景情况:
- 心脏利用各种基质获取能量,乳酸是压力期间的关键来源.
- 持续高的乳酸盐水平与患者的不良结果和死亡率相关.
- 肉二酶II (CNDP2) 催化乳酸中的Lac-Phe形成,影响食欲和脂肪组织.
研究的目的:
- 审查CNDP2在生理过程和疾病中的多方面的作用.
- 探索CNDP2在乳酸清除,肉素水解和氧化应激中的参与.
- 调查CNDP2与心脏代谢和脏疾病之间的关联.
主要方法:
- 对CNDP2的功能和疾病关联的文献综述.
- 分析CNDP2在代谢物调节中的作用,包括Lac-Phe.
- 探索CNDP2对氧化应激和基质利用的影响.
主要成果:
- CNDP2在乳酸清除和抑制食欲的代谢物Lac-Phe.的形成中起作用.
- 这种酶参与调节氧化应激和肉氨酸水解.
- 建议CNDP2与心脏代谢和脏疾病之间的关联.
结论:
- CNDP2是一种复杂的酶,具有多种不同的生理和病理作用.
- 需要进一步的研究才能充分阐明CNDP2的功能和治疗潜力.
- 了解CNDP2可能为治疗代谢和心血管疾病提供新的途径.
相关概念视频
Coronary Artery Disease II: Pathophysiology
3
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
3
Coronary Artery Disease I: Introduction
3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
63
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
63
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Electron Transport Chain: Complex I and II
12.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.1K


